Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
2000 2
2001 1
2003 3
2004 3
2005 4
2006 4
2007 6
2008 5
2009 7
2010 9
2011 6
2012 6
2013 10
2014 12
2015 7
2016 9
2017 9
2018 8
2019 10
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

117 results
Results by year
Filters applied: . Clear all
Page 1
Evaluation of Escherichia coli pathotypes associated with irritable bowel syndrome.
Dogan B, Belcher-Timme HF, Dogan EI, Jiang ZD, DuPont HL, Snyder N, Yang S, Chandler B, Scherl EJ, Simpson KW. Dogan B, et al. FEMS Microbiol Lett. 2018 Nov 1;365(22). doi: 10.1093/femsle/fny249. FEMS Microbiol Lett. 2018. PMID: 30299475
Irritable bowel syndrome (IBS) affects 10%-20% of people. Increased numbers of Escherichia coli (E. coli) correlate with symptoms, and patients respond to antimicrobials targeting E. coli. ...Escherichia coli capable
Irritable bowel syndrome (IBS) affects 10%-20% of people. Increased numbers of Escherichia coli (E. co
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
Distrutti E, Monaldi L, Ricci P, Fiorucci S. Distrutti E, et al. World J Gastroenterol. 2016 Feb 21;22(7):2219-41. doi: 10.3748/wjg.v22.i7.2219. World J Gastroenterol. 2016. PMID: 26900286 Free PMC article. Review.
In the last decade the impressive expansion of our knowledge of the vast microbial community that resides in the human intestine, the gut microbiota, has provided support to the concept that a disturbed intestinal ecology might promote development and maintenance of symptoms in …
In the last decade the impressive expansion of our knowledge of the vast microbial community that resides in the human intestine, the gut mi …
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.
Currò D, Ianiro G, Pecere S, Bibbò S, Cammarota G. Currò D, et al. Br J Pharmacol. 2017 Jun;174(11):1426-1449. doi: 10.1111/bph.13632. Epub 2016 Oct 25. Br J Pharmacol. 2017. PMID: 27696378 Free PMC article. Review.
Functional bowel disorders (FBD), mainly irritable bowel syndrome (IBS) and functional constipation (FC, also called chronic idiopathic constipation), are very common worldwide. ...The probiotic combination VSL#3 may be effective in inducing remission …
Functional bowel disorders (FBD), mainly irritable bowel syndrome (IBS) and functional constipation (FC, also ca …
Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis.
Zhuang X, Xiong L, Li L, Li M, Chen M. Zhuang X, et al. J Gastroenterol Hepatol. 2017 Jan;32(1):28-38. doi: 10.1111/jgh.13471. J Gastroenterol Hepatol. 2017. PMID: 27300149 Review.
BACKGROUND AND AIMS: Alterations of gut microbiota were assumed to be the etiology and pathogenesis of irritable bowel syndrome (IBS) in some studies. ...As compared with healthy controls, the SMDs of Bifidobacteria, Lactobacillus, Escherichia Coli
BACKGROUND AND AIMS: Alterations of gut microbiota were assumed to be the etiology and pathogenesis of irritable bowel synd
Effect of mild moxibustion on intestinal microbiota and NLRP6 inflammasome signaling in rats with post-inflammatory irritable bowel syndrome.
Bao CH, Wang CY, Li GN, Yan YL, Wang D, Jin XM, Wu LY, Liu HR, Wang XM, Shi Z, Wu HG. Bao CH, et al. World J Gastroenterol. 2019 Aug 28;25(32):4696-4714. doi: 10.3748/wjg.v25.i32.4696. World J Gastroenterol. 2019. PMID: 31528095 Free PMC article.
BACKGROUND: About one-third of refractory irritable bowel syndrome (IBS) cases are caused by gastrointestinal (GI) infection/inflammation, known as post-infectious/post-inflammatory IBS (PI-IBS). ...Mild moxibustion remarkably increased the relative DNA abund …
BACKGROUND: About one-third of refractory irritable bowel syndrome (IBS) cases are caused by gastrointestinal (GI) infe …
The possible role of bacteria, viruses, and parasites in initiation and exacerbation of irritable bowel syndrome.
Shariati A, Fallah F, Pormohammad A, Taghipour A, Safari H, Chirani AS, Sabour S, Alizadeh-Sani M, Azimi T. Shariati A, et al. J Cell Physiol. 2019 Jun;234(6):8550-8569. doi: 10.1002/jcp.27828. Epub 2018 Nov 27. J Cell Physiol. 2019. PMID: 30480810 Review.
Irritable bowel syndrome (IBS) is a prolonged and disabling functional gastrointestinal disorder with the incidence rate of 18% in the world. ...It appears that the main obligatory pathogens correspond with the IBS disease, Clostridium difficile, Escherich
Irritable bowel syndrome (IBS) is a prolonged and disabling functional gastrointestinal disorder with the incidence rat
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators.
Barbaro MR, Fuschi D, Cremon C, Carapelle M, Dino P, Marcellini MM, Dothel G, De Ponti F, Stanghellini V, Barbara G. Barbaro MR, et al. Neurogastroenterol Motil. 2018 Jun 28:e13388. doi: 10.1111/nmo.13388. Online ahead of print. Neurogastroenterol Motil. 2018. PMID: 29956419
BACKGROUND: Intestinal permeability is altered in a subgroup of irritable bowel syndrome (IBS) patients and may contribute to symptom development. The aim of this study was to evaluate the in vitro effect of the probiotic Escherichia coli Nissle …
BACKGROUND: Intestinal permeability is altered in a subgroup of irritable bowel syndrome (IBS) patients and may contrib …
Association of enteroaggregative Escherichia coli with irritable bowel syndrome.
Sobieszczańska BM, Osek J, Waśko-Czopnik D, Dworniczek E, Jermakow K. Sobieszczańska BM, et al. Clin Microbiol Infect. 2007 Apr;13(4):404-7. doi: 10.1111/j.1469-0691.2006.01669.x. Clin Microbiol Infect. 2007. PMID: 17359324 Free article.
Increased numbers of faecal Enterobacteriaceae are observed among patients with irritable bowel syndrome. Escherichia coli strains are present in the lower intestine of humans, and may include several potentially pathogenic adhesive pathotypes. …
Increased numbers of faecal Enterobacteriaceae are observed among patients with irritable bowel syndrome. Escherichi
Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome.
Bednarska O, Walter SA, Casado-Bedmar M, Ström M, Salvo-Romero E, Vicario M, Mayer EA, Keita ÅV. Bednarska O, et al. Gastroenterology. 2017 Oct;153(4):948-960.e3. doi: 10.1053/j.gastro.2017.06.051. Epub 2017 Jul 13. Gastroenterology. 2017. PMID: 28711627 Free PMC article.
BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is associated with intestinal dysbiosis and symptoms of IBS develop following gastroenteritis. ...METHODS: Colon biopsies from 32 women with IBS and 15 age-matched healthy women (controls) were mounted in …
BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is associated with intestinal dysbiosis and symptoms of IBS devel …
[The role of Escherichia coli strain Nissle 1917 in the gastro-intestinal diseases].
Różańska D, Regulska-Ilow B, Choroszy-Król I, Ilow R. Różańska D, et al. Postepy Hig Med Dosw (Online). 2014 Nov 6;68:1251-6. doi: 10.5604/17322693.1127882. Postepy Hig Med Dosw (Online). 2014. PMID: 25380207 Review. Polish.
Assessing the importance of EcN in treatment of other gastrointestinal disorders, authors of the studies observed, that in patients with irritable bowel syndrome, who receiving this probiotic there was a pain, nausea and bloating reduction. ...This probiotic …
Assessing the importance of EcN in treatment of other gastrointestinal disorders, authors of the studies observed, that in patients with …
117 results
Jump to page
Feedback